Nadia is a Patent Attorney in the Biotechnology and Life Sciences Group. She joined the team in 2015. Her work involves filing and prosecution of patent applications in the UK, Europe and worldwide.
Prior to entering the profession, Nadia received a PhD from the Clinical Sciences Centre of Imperial College London, uncovering the molecular mechanisms involved in insulin resistance and diabetes. Her work investigated the role of specific protein interactions within the insulin signalling network and their relevance to pathological states such as glucose intolerance, obesity, infertility and loss of spatial and working memory. She has specialist knowledge in a variety of topics including biochemical techniques, enzyme-based assays and in vivo transgenic animals.
Nadia also has a BSc (Hons) in Molecular Biology from the University of Manchester, and has worked at Thomas Jefferson University in Philadelphia on protein-based therapies to target and shrink tumours. Her work is published in the Journal of Biological Chemistry. Additionally, Nadia assists as an Editor for an online science and technology journal.
PhD Clinical Sciences, Imperial College London
BSc (Hons) Molecular Biology, University of Manchester